Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled study.
Pawełczyk T, Piątkowska-Janko E, Bogorodzki P, Gębski P, Grancow-Grabka M, Trafalska E, Żurner N, Pawełczyk A. Pawełczyk T, et al. Among authors: zurner n. Schizophr Res. 2018 May;195:168-175. doi: 10.1016/j.schres.2017.10.013. Epub 2017 Nov 2. Schizophr Res. 2018. PMID: 29079060 Clinical Trial.
Telomerase level increase is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized clinical trial.
Pawełczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Żurner N, Pawełczyk A. Pawełczyk T, et al. Among authors: zurner n. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Apr 20;83:142-148. doi: 10.1016/j.pnpbp.2017.12.008. Epub 2017 Dec 11. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29241838 Clinical Trial.
An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
Pawełczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Żurner N, Pawełczyk A. Pawełczyk T, et al. Among authors: zurner n. Psychopharmacology (Berl). 2019 Sep;236(9):2811-2822. doi: 10.1007/s00213-019-05258-4. Epub 2019 May 17. Psychopharmacology (Berl). 2019. PMID: 31098654 Free PMC article. Clinical Trial.
13 results